158 related articles for article (PubMed ID: 2912896)
21. Immunogenicity and protective efficacy of Vibrio cholerae outer membrane vesicles in rabbit model.
Roy N; Barman S; Ghosh A; Pal A; Chakraborty K; Das SS; Saha DR; Yamasaki S; Koley H
FEMS Immunol Med Microbiol; 2010 Oct; 60(1):18-27. PubMed ID: 20528929
[TBL] [Abstract][Full Text] [Related]
22. Antigens involved in resistance to mucosal association by Vibrio cholerae.
Narendranathan R; Lutze LH; Jackson GD; Cooper GN
J Med Microbiol; 1988 Feb; 25(2):129-38. PubMed ID: 3339633
[TBL] [Abstract][Full Text] [Related]
23. Immunological responses of rabbits to various somatic and secreted antigens of Vibrio cholerae after intra-duodenal inoculation.
Kabir S
J Med Microbiol; 1987 Aug; 24(1):29-40. PubMed ID: 3612742
[TBL] [Abstract][Full Text] [Related]
24. Immune response to the mannose-sensitive hemagglutinin in patients with cholera due to Vibrio cholerae O1 and O0139.
Qadri F; Jonson G; Begum YA; Wennerås C; Albert MJ; Salam MA; Svennerholm AM
Clin Diagn Lab Immunol; 1997 Jul; 4(4):429-34. PubMed ID: 9220159
[TBL] [Abstract][Full Text] [Related]
25. Identity of hemolysins produced by Vibrio cholerae non-O1 and V. cholerae O1, biotype El Tor.
Yamamoto K; Ichinose Y; Nakasone N; Tanabe M; Nagahama M; Sakurai J; Iwanaga M
Infect Immun; 1986 Mar; 51(3):927-31. PubMed ID: 3081448
[TBL] [Abstract][Full Text] [Related]
26. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
Kundu J; Mazumder R; Srivastava R; Srivastava BS
FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
[TBL] [Abstract][Full Text] [Related]
27. Detection of Vibrio cholerae with monoclonal antibodies specific for serovar O1 lipopolysaccharide.
Adams LB; Henk MC; Siebeling RJ
J Clin Microbiol; 1988 Sep; 26(9):1801-9. PubMed ID: 3053778
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity of Vibrio cholerae O1 toxin-coregulated pili in experimental and clinical cholera.
Hall RH; Losonsky G; Silveira AP; Taylor RK; Mekalanos JJ; Witham ND; Levine MM
Infect Immun; 1991 Jul; 59(7):2508-12. PubMed ID: 1711017
[TBL] [Abstract][Full Text] [Related]
29. Direct immunofluorescence assay for rapid environmental detection of Vibrio cholerae O1.
Goel AK; Tamrakar AK; Kamboj DV; Singh L
Folia Microbiol (Praha); 2005; 50(5):448-52. PubMed ID: 16475506
[TBL] [Abstract][Full Text] [Related]
30. Effect of chemical and heat inactivation on the antigenicity and immunogenicity of Vibrio cholerae.
Cryz SJ; Fürer E; Germanier R
Infect Immun; 1982 Oct; 38(1):21-6. PubMed ID: 7141690
[TBL] [Abstract][Full Text] [Related]
31. Antisera to selected outer membrane proteins of Vibrio cholerae protect against challenge with homologous and heterologous strains of V. cholerae.
Das M; Chopra AK; Cantu JM; Peterson JW
FEMS Immunol Med Microbiol; 1998 Dec; 22(4):303-8. PubMed ID: 9879921
[TBL] [Abstract][Full Text] [Related]
32. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
Liao J; Gibson JA; Pickering BS; Watnick PI
mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
[TBL] [Abstract][Full Text] [Related]
33. Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology.
Levinson KJ; De Jesus M; Mantis NJ
Infect Immun; 2015 Apr; 83(4):1674-83. PubMed ID: 25667263
[TBL] [Abstract][Full Text] [Related]
34. Surface expression of Helicobacter pylori HpaA adhesion antigen on Vibrio cholerae, enhanced by co-expressed enterotoxigenic Escherichia coli fimbrial antigens.
Tobias J; Lebens M; Wai SN; Holmgren J; Svennerholm AM
Microb Pathog; 2017 Apr; 105():177-184. PubMed ID: 28215587
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the human immune response to outer membrane proteins of Vibrio cholerae.
Sears SD; Richardson K; Young C; Parker CD; Levine MM
Infect Immun; 1984 May; 44(2):439-44. PubMed ID: 6715044
[TBL] [Abstract][Full Text] [Related]
36. Identification and occurrence of Vibrio cholerae flagellar core proteins in isolated outer membrane.
Richardson K; Parker CD
Infect Immun; 1985 Mar; 47(3):674-9. PubMed ID: 3972446
[TBL] [Abstract][Full Text] [Related]
37. Immune mechanisms and protective antigens of Vibrio cholerae serogroup O139 as a basis for vaccine development.
Jonson G; Osek J; Svennerholm AM; Holmgren J
Infect Immun; 1996 Sep; 64(9):3778-85. PubMed ID: 8751929
[TBL] [Abstract][Full Text] [Related]
38. Immunochemical characterization of an Ogawa-Inaba common antigenic determinant of Vibrio cholerae O1.
Villeneuve S; Boutonnier A; Mulard LA; Fournier JM
Microbiology (Reading); 1999 Sep; 145 ( Pt 9)():2477-2484. PubMed ID: 10517600
[TBL] [Abstract][Full Text] [Related]
39. Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity.
Losonsky GA; Lim Y; Motamedi P; Comstock LE; Johnson JA; Morris JG; Tacket CO; Kaper JB; Levine MM
Clin Diagn Lab Immunol; 1997 May; 4(3):264-9. PubMed ID: 9144361
[TBL] [Abstract][Full Text] [Related]
40. Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera.
Qadri F; Ahmed F; Karim MM; Wenneras C; Begum YA; Abdus Salam M; Albert MJ; McGhee JR
Clin Diagn Lab Immunol; 1999 Nov; 6(6):812-8. PubMed ID: 10548569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
